attila a seyhan
Brown University
Providence, United States
Associate Editor
Cancer Molecular Targets and Therapeutics
- Frontiers in Oncology
- Cancer Molecular Targets and Therapeutics
- Editorial Board
Type at least 3 characters
669 editors
Shape the future of research in your field
Join the board
Editors
Associate Editors
qing-bai she
University of Kentucky
Lexington, United States
Associate Editor
Cancer Molecular Targets and Therapeutics
qiang shen
LSU Health Sciences Center New Orleans, Louisiana State University
New Orleans, United States
Associate Editor
Cancer Molecular Targets and Therapeutics
zhi sheng
Virginia Tech
Blacksburg, United States
Associate Editor
Cancer Molecular Targets and Therapeutics
tristan m sissung
National Institutes of Health (NIH)
Bethesda, United States
Associate Editor
Cancer Molecular Targets and Therapeutics
jonathan w. song
The Ohio State University
Columbus, United States
Associate Editor
Cancer Molecular Targets and Therapeutics
lele song
Eighth Medical Center of the General Hospital of the Chinese People's Liberation Army
Beijing, China
Associate Editor
Cancer Molecular Targets and Therapeutics
yong sang song
Seoul National University
Seoul, Republic of Korea
Associate Editor
Cancer Molecular Targets and Therapeutics
carole sourbier
United States Food and Drug Administration
Silver Spring, United States
Associate Editor
Cancer Molecular Targets and Therapeutics
triantafyllos stylianopoulos
University of Cyprus
Nicosia, Cyprus
Associate Editor
Cancer Molecular Targets and Therapeutics
matthew k. summers
The Ohio State University
Columbus, United States
Associate Editor
Cancer Molecular Targets and Therapeutics
daekyu sun
University of Arizona
Tucson, United States
Associate Editor
Cancer Molecular Targets and Therapeutics
nikos tapinos
Brown University
Providence, United States
Associate Editor
Cancer Molecular Targets and Therapeutics
xiaobing tian
Brown University
Providence, United States
Associate Editor
Cancer Molecular Targets and Therapeutics
kwong tsang
Precision Biologics, Inc.
Rockville, United States
Associate Editor
Cancer Molecular Targets and Therapeutics
andrzej tukiendorf
Opole University
Opole, Poland
Associate Editor
Cancer Molecular Targets and Therapeutics